Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02148029 · ClinicalTrials.gov registry record · NA
Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT02148029: Completed NA study, sponsored by VA Office of Research and Development.
NCT02148029 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02148029, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
Despite standard care, 25%-50% of patients with clots in the deep veins of the arms and legs progress to chronic post-clot problems resulting in significant disability, loss of productivity, and healthcare costs. Reverse flow in the veins from an organizing clot is the primary cause of post-clot problems. Veins with early clot breakdown have a lower incidence of reverse flow. The investigators have observed that clot breakdown is enhanced by increased blood flow and that moderate arm and leg exercise result in increased venous blood flow. Hence, the investigators predict that a supervised exercise program in patients with deep vein clots could increase leg vein blood flow, accelerate clot breakdown, and decrease the risk of post clot problems. The primary hypothesis is that increased blood flow across the clot (induced by supervised exercise) will increase clot breakdown and decrease severity of post clot problems. The investigators are conducting a randomized clinical trial of standard therapy compared to progressive exercise training in patients with leg deep vein clots.
Interventions
- OTHER Exercise
- OTHER Standard Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2014-09-15 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02148029
The ClinicalTrials.gov registry entry for NCT02148029 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.
NCT02148029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02148029 about?
NCT02148029 is a clinical study titled "Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome". Despite standard care, 25%-50% of patients with clots in the deep veins of the arms and legs progress to chronic post-clot problems resulting in significant disability, loss of productivity, and healthcare costs. Reverse flow in the veins from an organizing clot is the primary cause of post-clot pro...
What is the current status of trial NCT02148029?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2014-09-15. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT02148029?
The interventions under investigation include: Exercise (OTHER), Standard Care (OTHER).
Who is sponsoring clinical trial NCT02148029?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.